news

BioDuro & Silexon Form Strategic Collaboration to Develop New Anti-Cancer Drugs

BioDuro and Silexon collaborate on new anti-cancer drugs, leveraging advanced NASH models for accelerated preclinical testing and development | BioDuro-Sundia
December 03, 2020

Congratulations! Innocare‘s Orelabrutinib has been approved by NMPA for Commercial in China!

InnoCare Pharma's BTK inhibitor, Orelabrutinib, receives NMPA approval for commercialization in China, targeting mantle cell lymphoma and chronic lymphocytic ...
November 22, 2020

Congratulations to TaiGen’s Flu Antiviral Drug TG-1000 for Receiving FDA approval of IND

TaiGen Biotechnology has received FDA approval for the clinical trial application of their new influenza antiviral drug, TG-1000, targeting influenza A and B.
November 02, 2020

Congratulations to Longwood Biopharmaceuticals for LW402 Accepted for Clinical Trial

BioDuro-Sundia assists Longwood Biopharmaceuticals to complete the API production research of LW402 tablets | For the treatment of Rheumatoid Arthritis.
September 26, 2020

BioDuro and Sundia Partner as an Industry Leading Contract Research, Development and Manufacturing Organization

BioDuro and Sundia Partner as an Industry Leading Contract Research, Development and Manufacturing Organization (CRDMO) | Headquatered in the United States
September 25, 2020

Congratulations to TaiGen for Anti-Influenza Drug TG-1000 Approved for Clinical Trial

Congratulations to TaiGen for their anti-influenza drug TG-1000 and capsule (CXHL2000100、CXHL2000099) has obtained IND approval from the CDE ...
June 04, 2020

Congratulations to Fosun Pharma for Selective BCL-2 Inhibitor FCN-338 Accepted for Clinical Trial

Congratulations to Fochon Pharmaceuticals (Fosun Pharma subsidiary) for their selective BCL-2 inhibitor FCN-338 and tablet (CXHL2000200, CXHL2000201, ...)
May 28, 2020

New Preclinical Models for MASH/NASH Provide Strong Clinical Relevance and Shortened Timelines

Availability of two new preclinical models for Non-alcoholic steatohepatitis (NASH) that highly resemble clinical progression of the disease and do so ...
May 26, 2020
Total 97 12...45678910...1213
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all